peptides ghk-cu injection - Research Peptide Peptiq GHK-Cu Copper Peptide Micro-Infusion

Storage & Handling Ships overnight refrigerated

20 units per day on a 1 ml insulin syringe, equal to 10 mg per day

The FDAs position is unambiguous: BPC-157 "lacks sufficient safety data and has not been shown to be safe or effective in humans." Key implications: Compounding pharmacies cannot legally compound medications containing BPC-157 under Section 503A or 503B Marketing with therapeutic claims violates federal law regardless of disclaimers Warning letters have been issued to companies marketing BPC-157 as a therapeutic agent WADA Prohibition The World Anti-Doping Agency classifies BPC-157 as a prohibited substance under class S0: Non-Approved Substances , effective January 2023

Prescription drugs should only be used under the care of a health care professional because they are used to treat specific conditions and may cause serious side effects